AzTrials
AzTrials

Metabolic DisturbanceNCT05569837

The Effect of Irregular Meal Pattern Providing Hypo-energetic Diet on Energy Expenditure and Metabolism

A study testing Regular meal pattern and Irregular meal pattern in people with Metabolic Disturbance and Obesity, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study we will compare the effect of two different meal patterns. Firstly, participants will consume a diet providing their estimated energy requirement for a 7 day standardisation period (6 meals per day). Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Metabolic Disturbance, Obesity
What is being tested?
Regular meal pattern and Irregular meal pattern
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4 participants
Where
1 siteUnited Kingdom
Study dates
15 Dec 2021to 30 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • BMI between 18.5 and 30 kg/m2,
  • Age between 18 and 45y,
  • Non-smokers,
  • Non high-alcohol consumers (≥ 14 units/week),
  • Regular menstruation or on the oral contraceptive pills,
  • Their weight is stable during the previous 3 months,
  • No self-reported history of serious medical conditions and not under medication.

Who cannot join

  • Pregnant or lactating women
  • Smokers
  • High-alcohol consumers (≥ 14 units/week)
  • Subjects with high score for depression using Becks Depression Inventory
  • subjects Eating Attitudes Test (EAT-26) score >20
  • Subjects who on diet or seeking to lose weight
  • Subjects with high consumption of coffee or tea > 3 cups/day

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The University of Nottingham

    Nottingham, Nottinghamshire, NG7 2RD

Other trials in United Kingdom

About this study

Official title: The Effect of Irregular Meal Pattern Providing Hypo-energetic Diet on Energy Expenditure, Metabolism and Circadian Rhythm: a Randomized Controlled Trial

In this study we will compare the effect of two different meal patterns. Firstly, participants will consume a diet providing their estimated energy requirement for a 7 day standardisation period (6 meals per day). After a one day laboratory visit, this will be followed by a 14 day intervention period when participants will randomly follow a regular meal pattern (6 meals/d) or an irregular meal pattern (3-9 meals/d). Following a further laboratory visit day, they will then consume the previous standardisation diet for a further 3 days. The energy intake provided will be calculated to provide less energy than subjects are using which may result in approximately 2kg of weight loss. Participants will attend a screening visit in which they will complete questionnaires on medical health, eating habits and physical activity. In the laboratory visit, participants will be fasting and for 3 h after intake of a test drink, measurements will be taken of energy expenditure, fasting glucose, fasting gut hormones, fasting lipids and fasting insulin. A test meal will be offered. A questionnaire of subjective appetite ratings will be assessed while fasting, after the test drink, after the test meal, and during the intervention. Continuous interstitial glucose monitoring will be undertaken during the whole study period, Core body temperature will be measured before and after the intervention period. Also, wrist temperature will be measured during the whole study period.

Read the detailed description

Experimental protocol:

28 women who are a healthy weight or overweight (aged 18-45 years) will be recruited to a randomized parallel trial to follow one of two 14-d hypo-energetic diets. Firstly, participants will consume a diet providing their estimated energy requirement (6 meals/day) for a 7 day standardisation period. After a one day laboratory visit, this will be followed by a 14 day intervention period when participants will follow a regular meal pattern (6 meals/d) or an irregular meal pattern (3-9 meals/d) (energy deficit of 800kcal/ 24h in both diets) (identical foods provided on both interventions whilst otherwise free living). Following a further laboratory visit day, they will then consume the previous standardisation diet providing their estimated energy requirement (6 meals/day) for a further 3 days. All foods to be consumed during the study will be provided to free of charge. These will comprise foods commonly consumed in the British diet and will be consumed in amounts designed to provide 800kcal/24h less than estimated energy requirements in the intervention period. Participants will attend the laboratory visits fasting and a blood sample will be obtained for fasting glucose, insulin and lipids. A test drink will then be given and over the following three hours measurements will be taken of energy expenditure (TEF). An ad libitum pasta test meal will be offered three hours after the test drink has been given. Subjective appetite ratings will be assessed while fasting, after the test drink, after the ad libitum meal, and during the intervention. Continuous interstitial glucose monitoring will be undertaken throughout the study. Ambulatory activity pattern measurement will be assessed in the intervention period. Core body temperature will be measured during the last 3 days of the first standardisation period, and during the final three standardisation days. Peripheral body temperature will be measured throughout the study period using a small i- button secured to the wrist. The study will commence at the early phase of the menstrual cycle (days1-7). A constant sleep-wake (and light exposure) routine will be followed for the whole study period which will be assessed by a written questionnaire form

Being tested
Regular meal pattern, Irregular meal pattern
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Regular meal patternOther

    6 meals every day

  • Irregular meal patternOther

    It consists of consuming a different number of meals every day (between 3 and 9).

Study groups in NCT05569837
Study groupRoleWhat they receive
Regular meal patternExperimentalParticipants will follow a regular meal pattern for 14 days
Receives: Other: Regular meal pattern
Irregular meal patternExperimentalParticipants will follow an irregular meal pattern for 14 days
Receives: Other: Irregular meal pattern

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline thermic effect of food in kcal at 2 weeks intervention

    Indirect calorimetry (GEM system; Europa Scientific Ltd.) will be used to determine the resting energy expenditure (REE) and thermic effect of food (TEF). REE will be measured in the fasted state for 20 min. The TEF will be measured for periods of 15 min at 30-min intervals during the 3 h after test drink (milkshake) consumption.

    Measured: Over 3 hours for 2 days

Secondary outcomes (11)
  1. Change from baseline body Weight in kilograms at 2 weeks intervention

    Body weight

    Measured: 1 day before intervention and 1 day after intervention

  2. Change in subjective appetite

    a booklet will be given to record the subjective appetite (hunger, fullness and desire to eat) using visual analogue scales (VAS) before and after each single meal on:

    1. The last day of the pre-standardization period,
    2. The first day of the post-intervention period.
    3. Pre-lab visit day.
    4. Post-lab visit day.
    5. Day 7 during the intervention period.
    6. Day 14 during intervention period.

    Measured: 2 days in lab visit, 1 day pre-intervention standardization period, 1 day post-intervention standardization period and 2 days in intervention period

  3. Continuous interstitial glucose

    Continuous interstitial glucose will be undertaken using a continuous glucose monitor (CGM) the FreeStyle Libre System during the whole study period

    Measured: 26 days

  4. Change from baseline fasting glucose in mmol/L at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum glucose

    Measured: 1 day before intervention and 1 day after intervention

  5. Change from baseline fasting insulin in mlU/L at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum insulin

    Measured: 1 day before intervention and 1 day after intervention

  6. Change from baseline fasting lipids in mmol/L at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting sample of serum total cholesterol, HDL cholesterol, LDL cholesterol and triacylglycerol.

    Measured: 1 day before intervention and 1 day after intervention

  7. Change from baseline fasting glucagon-like peptide1 in pM at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma glucagon-like peptide1(GLP-1).

    Measured: 1 day before intervention and 1 day after intervention

  8. Change from baseline fasting peptide YY in pg/ml at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma peptide YY (PYY).

    Measured: 1 day before intervention and 1 day after intervention

  9. Change from baseline fasting ghrelin in pg/ml at 2 weeks intervention

    A fasting blood samples will be taken, just before ingestion of the test drink to assess the mean of the fasting plasma ghrelin.

    Measured: 1 day before intervention and 1 day after intervention

  10. Change from baseline core body temperature in Celsius at 2 weeks intervention

    Core temperature will be assessed using an ingestible telemetry pill and associated monitor (e-Celsius Performance pill and monitor e-Celcius™ BodyCap).

    Measured: 3 days in pre and post intervention

  11. Peripheral wrist temperature in Celsius

    Wrist temperature will be assessed through a wireless iButton data logger

    Measured: 26 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2022
  2. Study start15 Dec 2021
  3. Primary completion30 Sep 2022
  4. Study completion30 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
4 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05569837
Sponsor's protocol ID
473- 2001
Status last verified
Nov 2022
First submitted
21 Sep 2022
Last updated
2 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Only anonymised individual personal data will be shared, upon specific request from other researchers, for example, in order to undertake a meta-analysis

Publications

  • Alhussain MH, Macdonald IA, Taylor MA. Irregular meal-pattern effects on energy expenditure, metabolism, and appetite regulation: a randomized controlled trial in healthy normal-weight women. Am J Clin Nutr. 2016 Jul;104(1):21-32. doi: 10.3945/ajcn.115.125401. Epub 2016 Jun 15.

    PubMed 27305952
  • Farshchi HR, Taylor MA, Macdonald IA. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr. 2004 Jul;58(7):1071-7. doi: 10.1038/sj.ejcn.1601935.

    PubMed 15220950
  • Farshchi HR, Taylor MA, Macdonald IA. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. Int J Obes Relat Metab Disord. 2004 May;28(5):653-60. doi: 10.1038/sj.ijo.0802616.

    PubMed 15085170
  • Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24. doi: 10.1093/ajcn/81.1.16.

    PubMed 15640455

Questions about this trial

What is this clinical trial studying?

A study testing Regular meal pattern and Irregular meal pattern in people with Metabolic Disturbance and Obesity, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline thermic effect of food in kcal at 2 weeks intervention (time frame: Over 3 hours for 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05569837, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in